OB/GYN

CEO Peter Meldrum said at a conference this week that Myriad's sales force "provides doctors [with] the tools to do counseling" in-house, and as a result, physicians can bill insurers directly for the service.

More OB/GYN sales reps, expanded direct-to-consumer marketing campaigns, and more company-hired physicians reaching out to other doctors are a few “initiatives [that] will be beneficial to the company in combating this weak economy,” Myriad CEO Peter Meldrum said during an earnings call this week.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.